Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 7317 99m 2?
Displaying drugs 11551 - 11575 of 12844 in total
Experimental
Matched Iupac: … [(5-carboxy-2-acetamidophenyl)carbamoyl]methanaminium …
Experimental
Matched Iupac: … (2S)-2-amino-5-ethanimidamidopentanoic acid …
Experimental
Matched Iupac: … (2-formyl-6-methoxyphenoxy)phosphonic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-(propyldisulfanyl)propanal …
Experimental
Matched Iupac: … 2-(4-fluorophenyl)ethan-1-ol …
Experimental
Matched Iupac: … (2S)-2-amino-3,3,3-trifluoropropanoic acid …
A non-essential amino acid that is involved in the metabolic control of cell functions in nerve and brain tissue. It is biosynthesized from ASPARTIC ACID and AMMONIA by asparagine synthetase. (From Concise Encyclopedia Biochemistry and Molecular Biology, 3rd ed)
Experimental
Matched Iupac: … (2R)-2-amino-3-carbamoylpropanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-6-carbamimidamidohexanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-4-oxobutanoic acid …
Experimental
Matched Iupac: … (2S)-2-hexanamido-4-sulfanylbutanoic acid …
N-(carboxycarbonyl)-D-phenylalanine is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. It targets the protein hypoxia-inducible factor 1-alpha inhibitor.
Experimental
Matched Iupac: … (2R)-2-(carboxyformamido)-3-phenylpropanoic acid …
N-(3-carboxypropanoyl)-L-norvaline is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. This medication is known to target n-acetylornithine carbamoyltransferase and putative ornithine carbamoyltransferase.
Experimental
Matched Iupac: … (2S)-2-(3-carboxypropanamido)pentanoic acid …
COP is under investigation for the treatment of Rheumatoid Arthritis, Mature B-Cell Lymphoma, and Noninflammatory Degenerative Joint Disease. COP has been investigated for the treatment of Diabetic Retinopathy.
Investigational
Matched Iupac: … [2-(N-methylcarbamimidamido)ethoxy]phosphonic acid …
Experimental
Matched Iupac: … N-(2-oxothiolan-3-yl)acetamide …
Experimental
Matched Iupac: … [4-(2-benzylphenoxy)butyl](methyl)amine …
Cimlanod is under investigation in clinical trial NCT02819271 (A First-in-Human Study of the Safety of Single Continuous Intravenous (IV) Infusions of CXL-1427 for up to 48 Hours in Healthy Volunteers).
Investigational
Matched Iupac: … N-hydroxy-5-methylfuran-2-sulfonamide …
Litoxetine is under investigation in clinical trial NCT03397771 (DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence).
Investigational
Matched Iupac: … 4-[(naphthalen-2-yl)methoxy]piperidine …
Acetyldinaline is under investigation in clinical trial NCT00005624 (CI-994 in Treating Patients With Advanced Myeloma).
Investigational
Matched Iupac: … 4-amino-N-(2-aminophenyl)benzamide …
DS-1211 is a potent and selective novel small molecule tissue-nonspecific alkaline phosphatase (TNAP) inhibitor.
Investigational
Matched Iupac: … (2R)-2-acetamido-4-methylpentanoic acid …
Investigational
Matched Iupac: … 8-[(2-hydroxyphenyl)formamido]octanoic acid …
3'-deoxyguanosine is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. This medication targets the protein purine nucleoside phosphorylase.
Experimental
Matched Iupac: … 2-amino-9-[(2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one …
OSI-7836 is a member of the nucleoside class of cytotoxic drugs of which gemcitabine is the market leader. OSI Pharmaceuticals develops OSI-7836 as a next-generation gemcitabine. The anti-tumor activity of OSI-7836 appeares to be less schedule dependent than gemcitabine. It is also more active than ara-C (another clinically used nucleoside...
Investigational
Matched Iupac: … 4-amino-1-[(2R,3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidine-2-thione …
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
Matched Iupac: … 4-[(7R,7aS)-7-hydroxy-1,3-dioxo-hexahydro-1H-pyrrolo[1,2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile …
Experimental
Matched Iupac: … (2S)-3-methyl-2-{8-thiatricyclo[7.4.0.0^{2,7}]trideca-1(13),2(7),3,5,9,11-hexaene-5-sulfonamido}butanoic …
Investigational
Matched Iupac: … {5-[(3,5-dichlorophenyl)sulfanyl]-4-(propan-2-yl)-1-[(pyridin-4-yl)methyl]-1H-imidazol-2-yl}methyl carbamate …
Displaying drugs 11551 - 11575 of 12844 in total